echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Huangtengsu glucose injection, a class 2 new drug of Anhui Shuanghe Pharmaceutical Co., Ltd., took 9 years to obtain the production approval

    Huangtengsu glucose injection, a class 2 new drug of Anhui Shuanghe Pharmaceutical Co., Ltd., took 9 years to obtain the production approval

    • Last Update: 2020-04-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Anhui Shuanghe Pharmaceutical Co., Ltd., a wholly-owned subsidiary of China Resources Shuanghe Pharmaceutical Co., Ltd., has applied for the production of Huangtengsu glucose injection (acceptance No.: x0407935), a class 2 new drug, which has been prepared and certified by the State Food and Drug Administration and is in the status of awaiting approval

    This means that for 9 years, the Huangtengsu glucose injection finally ushered in substantive progress

    It is understood that Huangtengsu glucose injection is a pure natural plant drug developed by our country

    This injection is the exclusive variety of Anhui Shuanghe

    The company applied for the drug as early as 2004, and applied for patent in 2005

    Then it was rated as a major science and technology special project in Wuhu City in 2008

    Patent information shows that the injection is not only effective and stable, but also has no adverse reactions

    In addition, Huangtengsu glucose injection is widely used in the treatment of gynecological diseases, with the efficacy of anti bacteria and anti viral infection

    According to IMS data, the global female drug market in 2012 has reached $about 130000000000, showing a sustained growth trend, and is expected to exceed $160 billion in 2014

    According to the financial report of China Resources Shuanghe, Anhui Shuanghe obtained the certificate of Anhui high tech enterprise in 2011, and can enjoy 15% income tax preference from 2011 to 2013

    The approval of Huangtengsu glucose injection will undoubtedly bring large-scale performance release to Anhui Shuanghe and China Resources Shuanghe

       
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.